# A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures

> **NCT02124564** · PHASE3 · COMPLETED · sponsor: **UCB Japan Co. Ltd.** · enrollment: 19 (actual)

## Conditions studied

- Epilepsy
- Partial-onset Seizures

## Interventions

- **DRUG:** Lacosamide

## Key facts

- **NCT ID:** NCT02124564
- **Lead sponsor:** UCB Japan Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2017-11-21
- **Final completion:** 2017-11-21
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2019-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02124564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02124564, "A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02124564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*